EcoDrugPlus

Melatonin Receptor 1a

Ensembl ID : ENSCDRG00005011664
Gene Symbol: MTNR1A
1 Cross references
216 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSCDRG00005011909
Gene Symbol: MTNR1B
3 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSCDRG00005000270
Gene Symbol: MME
3 Cross references
234 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSCDRG00005020004
Gene Symbol: METAP2
3 Cross references
230 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSCDRG00005021733
Gene Symbol: MAPT
3 Cross references
226 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSCDRG00005021983
Gene Symbol: MAPK1
1 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSCDRG00005005394
Gene Symbol: MAPK10
1 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSCDRG00005010666
Gene Symbol: MAPK14
3 Cross references
293 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSCDRG00005008768
Gene Symbol: MAPK3
1 Cross references
199 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSCDRG00005014970
Gene Symbol: MAPK8
3 Cross references
292 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSCDRG00005004915
Gene Symbol: MAPK9
3 Cross references
219 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 1

Ensembl ID : ENSCDRG00005002580
Gene Symbol: MAP2K1
3 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).